Health2Tech NYC – October 22, 2026

Marissa Fayer has spent 25+ years operating at the intersection of technology and women’s health. She’s CEO of DeepLook Medical, an FDA-cleared AI diagnostics company focused on improving cancer detection for patients with dense breast tissue, and CEO/founder of HERhealthEQ, a nonprofit that’s improved the health outcomes of 151,000+ women in 13 different countries by expanding access to medical devices and equipment. Marissa approaches women’s health as infrastructure: when properly funded and built, it drives measurable returns across economies, workforces, and communities. Previously, Marissa held executive roles at Hologic, Olympus, Maquet Getinge, and has consulted for organizations including Pfizer, the National Institutes of Health (NIH), NuVasive, and Boehringer Ingelheim. She currently serves as an Investment Committee Member of GG Ventures, a 2026-2028 World Economic Forum (WEF) Technology Fellow, is an active founding member of Milken Institute’s Women’s Health Committee, and advisor to Welwaze Medical, Impact.51, and TechThrive Ventures. Marissa is the author of Undervalued to Unavoidable: Women’s Health as Infrastructure. Marissa is a TEDx speaker (2019 TEDxLugano), has delivered keynotes at leading global healthcare conferences, and has been recognized as a Top 100 Women in Medtech and a Medtech Voice to Follow. Marissa can be found at www.marissafayer.com